# OnCo record hs-20089 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hs-20089/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hs-20089" ;
  schema:name "HS-20089"@en ;
  schema:description "HS-20089 is an experimental antibody-drug conjugate from Hansoh BioMedical R&D in phase 3 trials for ovarian cancer and endometrial cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/hs-20089/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HS-20089> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/> ;
  onco:targets <https://onco.cc/targets/b7h4/> ;
  onco:companies <https://onco.cc/companies/hansoh-pharma/> ;
  onco:trials <https://onco.cc/trials/nct06855069/>, <https://onco.cc/trials/nct06014190/> .